Patient Support Programs

In Canada, UCB Canada Inc. is proud to lead and support a number of patient‑focused programs and the efforts of healthcare professionals across the country.

Neurology


 

UCB Connects logo

UCB Connects is a patient support program designed for patients prescribed BRIVLERA® (oral solution format only) or NEUPRO® to support them in their journey.

To learn more, speak to your doctor or contact a member of the patient support program by calling 1-833-534-1257 or emailing info@ucbconnects.ca.

RX Helps One logo

RxHelp ONE is a patient choice program that allows patients to remain on branded BRIVLERA® (tablet format only) or VIMPAT® with little or no additional cost over the generic equivalent.

To learn more about the program, speak to your doctor or visit www.rxhelp.ca to download a free card that can be used at your local pharmacy.

Rare Disease


 

Onward logo

ONWARD is a comprehensive patient support service designed with purpose to address the unique needs of each person living with a rare disease and prescribed a UCB treatment.

To find out more visit www.ucbonward.com or reach out to a member of the patient support program at 1-855-ONWARD1 (1-855-669-2731).

Immunology


 

UCB Cares logo

The UCBCares Patient Support Program provides support to patients prescribed CIMZIA® or BIMZELX® and their physicians through every step of their treatment journey.

To learn more about UCBCares and access helpful resources, visit www.ucbcares.ca or by calling the program at 1-800-908-5555.

A smiling woman giving a presentation leans over a conference table where other individuals are seated with laptops open and pens in their hands

UCBEYOND Scholarship program

Established in 2006, the UCBeyond Scholarship Program has allocated more than 209 scholarships and over $1,000,000 to Canadian students who live with chronic inflammatory diseases (CIDs) reach above and beyond the boundaries of their disease and fulfill their educational ambitions. 
 

For more information, please visit www.ucbeyond.ca.